Somatostatin infusion withdrawal: a study of patients with migraine, cluster headache and healthy volunteers
- 1 April 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 102 (3) , 235-241
- https://doi.org/10.1016/s0304-3959(02)00204-x
Abstract
Migraine and cluster headache are the most common disabling primary headache syndromes and are typically episodic. A reliable method of triggering such headache attacks facilitates the study and treatment of these disorders. There is sufficient clinical and laboratory evidence to suggest thaKeywords
This publication has 22 references indexed in Scilit:
- Hypothalamic involvement in chronic migraineJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Human migraine modelsCephalalgia, 2001
- Letters to the EditorHeadache: The Journal of Head and Face Pain, 1998
- Treatment of Migraine Attacks with A Long-Acting Somatostatin Analogue (Octreotide, SMS 201-995)Cephalalgia, 1997
- Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraineNeuroReport, 1995
- Octreotide Dependency and Headache: A Case ReportCephalalgia, 1994
- Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case reportPain, 1991
- Headache in Acromegaly: Dramatic Improvement with the Somatostatin Analogue SMS 201–995The Clinical Journal of Pain, 1990
- Headache provocation by continuous intravenous infusion of histamine. Clinical results and receptor mechanismsPain, 1980
- Insulin induced hypoglycaemia in migraineJournal of Neurology, Neurosurgery & Psychiatry, 1971